For US Patients Only

For US Patients Only

What is preterm birth?

See if you're at risk

Makena subcutaneous
auto-injector

Get to know the auto‑injector

Makena Care Connection®

Discover personalized support for moms
TOP

IMPORTANT SAFETY INFORMATION

Indication

Makena is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history

Important Safety Information for Makena
(hydroxyprogesterone caproate injection)

Makena should not be used in women with any of the following:

You are now leaving makena.com. AMAG Pharmaceuticals is not responsible for the information contained in any of the linked third-party sites. Please review the site's Privacy Policy and Terms of Use, as AMAG's policies do not apply to third-party sites.

Cancel Continue

You are now leaving makena.com. AMAG Pharmaceuticals is not responsible for the information contained in any of the linked third-party sites. Please review the site's Privacy Policy and Terms of Use, as AMAG's policies do not apply to third-party sites.

Cancel Continue

At this time, it is important to know that Makena’s approval and product label remain unchanged. If you have any questions, please speak with your healthcare provider.

If you have been prescribed or are taking Makena and have questions about your prescription, please contact Makena Care Connection® by calling 1-800-847-3418 (M–F, 8AM–8PM ET) or emailing info@makenacareconnection.com.

©2019 AMAG Pharmaceuticals, Inc. All rights reserved. PP-MKN-US-00577 11/19